The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...

The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the ...

Marking the second global approval after Japan, the U.S. FDA has approved Datroway (datopotamab deruxtecan), a trophoblast cell surface antigen 2-directed antibody-drug conjugate (ADC) from Daiichi ...

These pluripotent cells are the most ubiquitous of all. Once removed from the blastocyst they lack the outer trophoblast structures for continued embryonic development, but they can theoretically ...

The inner cell mass gives rise to the fetus, while the surrounding trophectoderm transforms into the placenta. After implantation, the trophectoderm starts reshaping the endometrium. A layer of ...

A recent study has introduced a novel class of antibody-drug conjugates (ADCs) targeting trophoblast cell surface antigen 2 (TROP2), a protein overexpressed in pancreatic ductal adenocarcinoma (PDAC), ...

Precise visualization of the trophoblast cell surface antigen 2 (Trop2) biomarker can provide physicians with valuable insights for diagnosis, development of a personalized treatment plan ...

Precise visualization of the trophoblast cell surface antigen 2 (Trop2) biomarker can provide physicians with valuable insights for diagnosis, development of a personalized treatment plan ...

27, 2024 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from National Medical Products ...